Yifan Pharmaceutical Co., Ltd.
Shenzhen Stock Exchange 002019.SZ
Yifan Pharmaceutical Co., Ltd. Market Capitalization on January 14, 2025: USD 1.72 B
-
Yifan Pharmaceutical Co., Ltd. 52-week high Market Capitalization is USD 2.39 B on May 08, 2024, which is 39.23% above the current Market Capitalization.
-
Yifan Pharmaceutical Co., Ltd. 52-week low Market Capitalization is USD 1.59 B on February 05, 2024, which is -7.20% below the current Market Capitalization.
-
Yifan Pharmaceutical Co., Ltd. average Market Capitalization for the last 52 weeks is USD 2.02 B.
| Date | Market Capitalization | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) |
|---|
| CEO | Mr. Xian Feng Cheng |
| IPO Date | July 13, 2004 |
| Location | China |
| Headquarters | No. 50, Qinshan |
| Employees | 4,230 |
| Sector | Health Care |
| Industries | |
Yifan Pharmaceutical Co., Ltd. produces and sells drugs and medicines in China and internationally. It provides drugs across gynecology, pediatrics, orthopedics, and dermatology therapeutic areas; therapeutic infusion solutions; and pantothenic acid and Provitamin B5 products. The company also provides Chinese traditional medicines, women's health products, and blood tumor drugs. In addition, it offers APIs, including feed additives/animal health products, skin and hair care ingredients, functional food additives, and fine chemicals; and PBAT/PBS biodegradable resins and PVB films. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October 2016. Yifan Pharmaceutical Co., Ltd. was founded in 2000 and is based in Hangzhou, China.
Past 5 years
USD 0.79
USD 1.04
USD 2.97
USD 5.92
USD 2.17
StockViz Staff
January 15, 2025
Any question? Send us an email